Labetalol Hydrochloride contains not less than 98.0% and not more than 102.0% of C19H25ClN2O3, calculated on the dried substance.

共有 1 個藥物證書使用此成份

拉倍他洛鹽酸鹽
Labetalol Hydrochloride

• 申請商: 新雙隆生技股份有限公司
• 適應症: 擬交感神經β-接受體遮斷劑
• 發證日期: 2022-12-08